AAL
62
3
MMM
35
-3
ROK
51
-3
AON
34
-2
QRVO
9
-2
PEP
47
3
EQR
42
-3
TXN
33
-7
TAP
64
-2
AVB
55
-4
DD
53
-7
KHC
18
-2
FRT
39
-4
EW
41
5
MA
64
4
WM
65
-3
HD
52
-5
DG
27
4
ADT
33
-2
CHD
39
5
AAL
62
3
MMM
35
-3
ROK
51
-3
AON
34
-2
QRVO
9
-2
PEP
47
3
EQR
42
-3
TXN
33
-7
TAP
64
-2
AVB
55
-4
DD
53
-7
KHC
18
-2
FRT
39
-4
EW
41
5
MA
64
4
WM
65
-3
HD
52
-5
DG
27
4
ADT
33
-2
CHD
39
5
Financhill
Back

4Front Ventures 10K Form

Sell
39

FFNT.CX
4Front Ventures

Last Price:
0.03
Seasonality Move:
14.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FFNT.CX News And Ratings

See the #1 stock for the next 7 days that we like better than FFNT.CX

FFNT.CX Financial Statistics

Sales & Book Value

Annual Sales: $131.52M
Cash Flow: $-770.6K
Price / Cash Flow: 0
Annual Sales: $-0.07
Price / Book: 0

Profitability

EPS (TTM): -0.16320
Net Income (TTM): $-49.36M
Gross Margin: $61.95M
Return on Equity: 0%
Return on Assets: -13.5%

4Front Ventures Earnings Forecast

Key 4Front Ventures Financial Ratios

  • The Gross Profit Margin over the past 16 years for FFNT.CX is 47.10%.
  • The Selling, General & Administrative Expenses for FFNT.CX have been equal to 55.43% of Gross Profit Margin.
  • The Interest Expense is -15.06% of Operating Income.
  • The Net Earning history of FFNT.CX is -94.06% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

4Front Ventures Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: CNSX
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: FFNT.CX
Website: 4frontventures.com

Debt

Debt-to-Equity Ratio: -1.42
Current Ratio: 0.34
Quick Ratio: 0.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FFNT.CX Technical Analysis vs Fundamental Analysis

Sell
39
4Front Ventures (FFNT.CX) is a Sell

Is 4Front Ventures a Buy or a Sell?